Cargando…
Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
Graft versus host disease (GvHD) is a life-threating complication of allogeneic hematopoietic stem cell transplantation, which is initially treated with high dose corticosteroids. Approximately 50% of acute GvHD cases are resistant to steroid treatment, and two-year mortality rates in those steroid-...
Autores principales: | Kelly, Kilian, Rasko, John E. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577186/ https://www.ncbi.nlm.nih.gov/pubmed/34764962 http://dx.doi.org/10.3389/fimmu.2021.761616 |
Ejemplares similares
-
Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
por: Cheung, Tik Shing, et al.
Publicado: (2020) -
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
por: Stenger, Elizabeth, et al.
Publicado: (2022) -
Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
por: Ringdén, Olle, et al.
Publicado: (2022) -
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
por: Krüger, Thomas, et al.
Publicado: (2022) -
Adult human mesenchymal stromal cells and the treatment of graft versus host disease
por: Herrmann, Richard P, et al.
Publicado: (2014)